OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Assessing the post hoc effectiveness of tixagevimab−cilgavimab for prevention of SARS‐CoV‐2 infections in solid organ transplant recipients
Stanley C. Jordan, Sandy Joung, Minhao Wang, et al.
Transplant Infectious Disease (2023) Vol. 26, Iss. 1
Open Access | Times Cited: 5
Stanley C. Jordan, Sandy Joung, Minhao Wang, et al.
Transplant Infectious Disease (2023) Vol. 26, Iss. 1
Open Access | Times Cited: 5
Showing 5 citing articles:
The Long-Term Immunogenicity of mRNABNT162b Third Vaccine Dose in Solid Organ Transplant Recipients
Maria Antonella Zingaropoli, Mariasilvia Guardiani, Federica Dominelli, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 224-224
Open Access | Times Cited: 1
Maria Antonella Zingaropoli, Mariasilvia Guardiani, Federica Dominelli, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 224-224
Open Access | Times Cited: 1
Anti SARS-CoV-2 Monoclonal Antibodies in Pre-Exposure or Post-Exposure in No- or Weak Responder to Vaccine Kidney Transplant Recipients: Is One Strategy Better than Another?
Anais Romero, Charlotte Laurent, L Lebourg, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 381-381
Open Access | Times Cited: 1
Anais Romero, Charlotte Laurent, L Lebourg, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 381-381
Open Access | Times Cited: 1
Tixagevimab/cilgavimab prophylaxis against COVID-19 in solid organ transplant recipients: a systematic review and meta-analysis
Saeed Khorramnia, Zia Navidi, Amirhossein Orandi, et al.
Deleted Journal (2024) Vol. 38, Iss. 2, pp. 136-144
Open Access | Times Cited: 1
Saeed Khorramnia, Zia Navidi, Amirhossein Orandi, et al.
Deleted Journal (2024) Vol. 38, Iss. 2, pp. 136-144
Open Access | Times Cited: 1
Investigation of severe acute respiratory syndrome coronavirus 2 infection status in solid organ transplant recipients treated with tixagevimab/cilgavimab
Ririka Aihara, Keisuke Umemura, Y. Katada, et al.
Journal of Infection and Chemotherapy (2024) Vol. 30, Iss. 12, pp. 1222-1227
Closed Access
Ririka Aihara, Keisuke Umemura, Y. Katada, et al.
Journal of Infection and Chemotherapy (2024) Vol. 30, Iss. 12, pp. 1222-1227
Closed Access
Tixagevimab/Cilgavimab as SARS-CoV-2 Pre-Exposure Prophylaxis in Lung Transplant Recipients during the Omicron Wave: A Real-World Monocentric Experience
Andrea Cona, Alessandro Tavelli, Stefano Agrenzano, et al.
Microorganisms (2024) Vol. 12, Iss. 7, pp. 1436-1436
Open Access
Andrea Cona, Alessandro Tavelli, Stefano Agrenzano, et al.
Microorganisms (2024) Vol. 12, Iss. 7, pp. 1436-1436
Open Access
